Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
Visceral leishmaniasis (VL) is a fatal disease caused by the protozoa Leishmania infantum for which dogs are the main reservoirs. A vaccine against canine visceral leishmaniasis (CVL) could be an important tool in the control of human and CVL by reducing the infection pressure of L. infantum. Despit...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/20.500.12955/2090 https://doi.org/10.3390/vaccines11010111 |
Ejemplares similares: Vaccination with formulation of nanoparticles loaded with Leishmania amazonensis antigens confers protection against experimental visceral Leishmaniasis in hamster
- Nanoformulations with Leishmania braziliensis antigens triggered controlled parasite burden in vaccinated golden hamster (Mesocricetus auratus) against visceral Leishmaniasis
- A retrospective occurrence of clinical and laboratory leishmaniasis in humans from Jan 2016 to Jan 2021 in Baringo County, Kenya
- Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species
- Research mapping of Indonesia nano-lignocellulose fiber studies and its potential for industrial application
- High‑energy emulsification of Allium sativum essential oil boosts insecticidal activity against Planococcus citri with no risk to honeybees
- Aplicación de un método de extracción de ADN a partir de sangre canina sensible y de bajo costo para el diagnóstico molecular de Leishmania sp. = Application of a sensitive and low cost method for the extraction of DNA from canine blood to the molecular diagnosis of Leishmania sp.